Related references
Note: Only part of the references are listed.Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic
Tomas Reischig et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients
Marta Kantauskaite et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series
Caoilfhionn M. Connolly et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Mucosal associated invariant T cells are differentially impaired in tolerant and immunosuppressed liver transplant recipients
Arne Sattler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Inosine 5′-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients
Petra Glander et al.
TRANSPLANTATION (2021)
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing
Bernd Jahrsdoerfer et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Eva Schrezenmeier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
Sarah Mbaeyi et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors
Bernd Jahrsdoerfer et al.
JOURNAL OF IMMUNOLOGY (2021)
Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study-The COViNEPH Project
Alicja Debska-Slizien et al.
VACCINES (2021)
Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant
Nassim Kamar et al.
JAMA NETWORK OPEN (2021)
Planned Pregnancy in Kidney Transplantation. A Calculated Risk
Claudio Ponticelli et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series
Bilgin Osmanodja et al.
TRANSPLANTATION DIRECT (2021)
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Danilo Schmidt et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2021)
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
Nathalie Chavarot et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Ugur Sahin et al.
NATURE (2021)
Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury
Michael Oellerich et al.
NATURE REVIEWS NEPHROLOGY (2021)
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Nassim Kamar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Lucie Loyal et al.
SCIENCE (2021)
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
Jennifer L. Alejo et al.
TRANSPLANTATION (2021)
Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis
Rommel Ravanan et al.
TRANSPLANTATION (2021)
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
Hector Rincon-Arevalo et al.
SCIENCE IMMUNOLOGY (2021)
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients
Arne Sattler et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney Transplantation
Ekkehard Schutz et al.
CLINICAL CHEMISTRY (2020)
SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition
Arne Sattler et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study
Michael Oellerich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients
Samantha Slight-Webb et al.
JCI INSIGHT (2019)
Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation
N. Lachmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients
Benjamin J. D. Weist et al.
KIDNEY INTERNATIONAL (2015)
Digital Droplet PCR for Rapid Quantification of Donor DNA in the Circulation of Transplant Recipients as a Potential Universal Biomarker of Graft Injury
Julia Beck et al.
CLINICAL CHEMISTRY (2013)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation results from an aborted trial
Anders Asberg et al.
CLINICAL TRANSPLANTATION (2013)
Combined standard and novel immunosuppressive substances affect B-lymphocyte function
Mareen Matz et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation
Mareen Matz et al.
TRANSPLANT INTERNATIONAL (2012)
Randomized Trial Comparing Late Concentration-Controlled Calcineurin Inhibitor or Mycophenolate Mofetil Withdrawal
Jacqueline S. Mourer et al.
TRANSPLANTATION (2012)
Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus
Sebastian Eickenberg et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Mycophenolic Acid-Mediated Suppression of Human CD4+ T Cells: More Than Mere Guanine Nucleotide Deprivation
X. He et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Mycophenolic Acid Differentially Impacts B Cell Function Depending on the Stage of Differentiation
Jodi L. Karnell et al.
JOURNAL OF IMMUNOLOGY (2011)
Three-year observational follow-up of a multicenter, Randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant
Julio Pascual et al.
TRANSPLANTATION (2006)
Minimization of immunosuppressive therapy after renal transplantation: Results of a randomized controlled trial
Y Vanrenterghem et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals
G Cassese et al.
JOURNAL OF IMMUNOLOGY (2003)
Interleukin-6 is a growth factor for nonmalignant human plasmablasts
G Jego et al.
BLOOD (2001)